{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:46:47Z","timestamp":1783979207800,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":438,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"PRIN 2020"},{"name":"European Union - NextGenerationEU - AGE-It Spoke 3"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end-stage liver disease (MELD) score and its variations in predicting adverse outcomes [death, urgent heart transplant, and left ventricular assist device (LVAD) implant] among patients with AHF to assess the clinical associations of the MELD score in this population and to compare the efficacy of this tool with other prognostic scores in AHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this longitudinal prospective study, 162 patients with advanced heart failure (AHF) were enrolled; all patients included in the study were receiving the maximum tolerated medical therapy according to guidelines. The MELD score was measured at baseline and every 6 months during follow-up. All patients underwent echocardiographic assessment and cardiopulmonary testing, which included the evaluation of maximal oxygen uptake (VO2max) and the minute ventilation\/carbon dioxide production (VE\/VCO2) slope. The mean age of the study group was 57.7 \u00b1 11.6 years. There were 26 deaths, 5 urgent transplants, and 1 LVAD implantation during a follow-up period of 31.4 \u00b1 15.6 months. The mean New York Heart Association (NYHA) class was 2.8 \u00b1 0.5, ejection fraction (EF) was 26.3 \u00b1 6.5%, the mean VO2max was 11.7 \u00b1 3.5 mL\/kg\/min. Multiple regression analysis revealed a positive correlation between the MELD score and NT-proBNP (\u03b2 = 0.215; P = 0.041) and furosemide dosage (\u03b2 = 0.187; P = 0.040). Conversely, a negative correlation was observed between the MELD score and TAPSE (\u03b2 = \u22120.204; P = 0.047). Multivariate Cox regression on combined outcome shows a HR of 1.094 (95% CI 1.003\u20131.196) for unit increase in MELD considered as a continuous variable. The predictive role is independent by the effect of covariates considered in the analysis such as age, sex, NYHA class, EF, TAPSE, PASP, VO2max, NT-proBNP, MELD score worsening, and NT-proBNP increase. Changes in MELD score percentage, considered as a dichotomous variable (\u2264100% and &amp;gt;100%), were found to be predictors of mortality, urgent heart transplant and LVAD implant. Receiver operating characteristic (ROC) curves showed an area under the curve (AUC) of 0.887 for MELD score and composite outcome of death, urgent transplant, and need for LVAD. The predictive performance of MELD was even superior compared with MELD-Na, MELD-XI, MAGGIC risk score, and MECKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The MELD score and its longitudinal changes are effective predictors of adverse outcomes in AHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15002","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:48:39Z","timestamp":1733579319000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MELD Score Predicts Outcomes in Patients with Advanced Heart Failure: A Longitudinal Evaluation"],"prefix":"10.1093","volume":"12","author":[{"given":"Francesco","family":"Curcio","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Amarelli","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Chiappetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mattucci","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Flocco","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Issa","family":"Rammal","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Abete","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mazzella","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]},{"name":"Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Maiello","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Abete","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Naples \u2018Federico II\u2019 , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"key":"2026021804044748100_ehf215002-bib-0001","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cardfail.2021.10.011","article-title":"Innovations in heart transplantation: A review","volume":"28","author":"Coniglio","year":"2022","journal-title":"J Card Fail"},{"key":"2026021804044748100_ehf215002-bib-0002","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021804044748100_ehf215002-bib-0003","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026021804044748100_ehf215002-bib-0004","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/ehf2.12477","article-title":"Hepatorenal dysfunction identifies high-risk patients with acute heart failure: Insights from the RELAX-AHF trial","volume":"6","author":"Biegus","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2026021804044748100_ehf215002-bib-0005","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"2026021804044748100_ehf215002-bib-0006","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced liver disease study group. The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"2026021804044748100_ehf215002-bib-0007","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"2026021804044748100_ehf215002-bib-0008","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/lt.20906","article-title":"MELD-XI: A rational approach to \u2018sickest first\u2019 liver transplantation in cirrhotic patients requiring anticoagulant therapy","volume":"13","author":"Heuman","year":"2007","journal-title":"Liver Transpl"},{"key":"2026021804044748100_ehf215002-bib-0009","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.amjcard.2017.03.031","article-title":"Implications of alternative hepatorenal prognostic scoring systems in acute heart failure (from DOSE-AHF and ROSE-AHF)","volume":"119","author":"Grodin","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026021804044748100_ehf215002-bib-0010","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Meta-analysis global group in chronic heart failure. Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"2026021804044748100_ehf215002-bib-0011","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.ijcard.2012.06.113","article-title":"MECKI score research group. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis","volume":"167","author":"Agostoni","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026021804044748100_ehf215002-bib-0012","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026021804044748100_ehf215002-bib-0013","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"Castiglione","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2026021804044748100_ehf215002-bib-0014","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMra2207410","article-title":"Right ventricular failure","volume":"388","author":"Houston","year":"2023","journal-title":"N Engl J Med"},{"key":"2026021804044748100_ehf215002-bib-0015","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: Application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026021804044748100_ehf215002-bib-0016","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ejcts\/ezz337","article-title":"Impact of preoperative liver dysfunction on outcomes in patients with left ventricular assist devices","volume":"57","author":"Yalcin","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026021804044748100_ehf215002-bib-0017","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.athoracsur","article-title":"Model for end-stage liver disease score independently predicts mortality in cardiac surgery","volume":"107","author":"Hawkins","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2026021804044748100_ehf215002-bib-0018","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4149\/BLL_2021_019","article-title":"Impact of model for end-stage liver disease (MELD) score for mortality in patients undergoing coronary bypass surgery","volume":"122","author":"Dolapoglu","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"2026021804044748100_ehf215002-bib-0019","doi-asserted-by":"publisher","first-page":"14420","DOI":"10.1038\/s41598-021-93952-9","article-title":"Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair","volume":"11","author":"Tanaka","year":"2021","journal-title":"Sci Rep"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/839\/66952957\/eschf_12_2_839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/839\/66952957\/eschf_12_2_839.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:04:51Z","timestamp":1771405491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/2\/839\/8487984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,7]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15002","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"2024-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}